- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04577547
Food, Activity and Behavior Study (FAB)
January 9, 2023 updated by: USDA Grand Forks Human Nutrition Research Center
Efficacy of the Dietary Guidelines for Americans and the Physical Activity Guidelines for Americans for Weight Control
The purpose of this research is to test the effects of the Dietary and Physical Activity Guidelines for Americans on health and on eating and exercise behaviors.
Study Overview
Status
Withdrawn
Conditions
Detailed Description
The Dietary Guidelines for Americans (DGA), which include the Physical Activity Guidelines for Americans (PAGA), is the primary United States (U.S) government resource for weight control.
The researchers propose that chronic, low grade inflammation (CLGI) limits weight control by acting upon physiological and behavioral factors that moderate weight control.
Diet and exercise reduce CLGI and provide weight control, but no one has investigated the efficacy of the DGA and PAGA to reduce CLGI, whether reduced CLGI promotes greater weight control, and the moderating roles of physiological and behavioral factors on the association of reduced CLGI with weight control.
To accomplish this, the researchers will conduct a 6-month trial in 224 obese adults; a 3-month controlled feeding trial with four dietary arms; 1) DGA with weight loss, 2) Western diet with weight loss,3) DGA diet weight maintenance, 4) Western diet weight maintenance.
Each dietary arm will have PAGA-recommended exercise and non-exercise arms.
Post-trial is a 3-month weight maintenance period.
The primary outcome is change in C-reactive protein (CRP), a marker of CLGI.
The results will inform the DGA and PAGA; thereby helping clinicians, public health workers, and policymakers to improve the health of Americans.
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Dakota
-
Grand Forks, North Dakota, United States, 58203
- USDA Grand Forks Human Nutrition Research Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Obese (BMI 30.0 kg/m2 - 350 lbs [maximum weight for dual energy x-ray absorptiometry (DXA) machine])
- No contraindications to participate in exercise
- hs-CRP level ≥3.0 and ≤10.0 mg/L or two consecutive measures of >10.0 mg/L measured two weeks apart
- Access to high-speed internet
Exclusion Criteria:
- Taking chronic anti-inflammatory medications
- Being pregnant, lactating, or planning to become pregnant
- Diagnosed eating disorder
- Taking weight loss medication
- Smoking
- Overt hypothyroidism
- Cancer
- Physical conditions that prevent safe exercise
- Liking of <3 out of 10 for all available physical activity modes
- Currently exercising for more than 30 minutes per day >3 days per week
- Unwilling to continue with current exercise routine
- Not willing to comply with all study requirements
- Blood pressure greater than 140/90
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Dietary Guidelines (DGA) diet with weight loss (WL) & exercise
Menu to provide DGA-recommended food group amounts at a calorie level to promote weight loss with Physical Activity Guidelines for Americans (PAGA)-recommended exercise
|
Intake of DGA weight loss 8 day rotating menu & PAGA-recommended exercise
|
|
Experimental: DGA diet with WL & no exercise
Menu to provide DGA-recommended food group amounts at a calorie level to promote weight loss with no exercise
|
Intake of DGA weight loss 8 day rotating menu & no exercise
|
|
Experimental: DGA diet weight maintenance (WM) & exercise
Menu to provide DGA-recommended food group amounts at a calorie level to promote weight maintenance with PAGA-recommended exercise
|
Intake of DGA weight maintenance 8 day rotating menu & PAGA-recommended exercise
|
|
Experimental: DGA diet WM & no exercise
Menu to provide DGA-recommended food group amounts at a calorie level to promote weight maintenance with no exercise
|
Intake of DGA weight maintenance 8 day rotating menu & no exercise
|
|
Experimental: Western diet with WL & exercise
Western-type menu to provide a calorie level to promote weight loss with PAGA-recommended exercise
|
Intake of Western-type weight loss 8 day rotating menu & PAGA-recommended exercise
|
|
Experimental: Western diet with WL & no exercise
Western-type menu to provide a calorie level to promote weight loss with no exercise
|
Intake of Western-type weight loss 8 day rotating menu & no exercise
|
|
Experimental: Western diet WM exercise
Western-type menu to provide a calorie level to promote weight maintenance with PAGA-recommended exercise
|
Intake of Western-type weight maintenance 8 day rotating menu & PAGA-recommended exercise
|
|
Experimental: Western diet WM no exercise
Western-type menu to provide a calorie level to promote weight maintenance with no exercise
|
Intake of Western-type weight maintenance 8 day rotating menu & no exercise
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in C-reactive protein (CRP)
Time Frame: Weeks 0, 2, 4, 6, 8, 10, 12, 24
|
The effect of diet and exercise on CRP
|
Weeks 0, 2, 4, 6, 8, 10, 12, 24
|
|
Relative reinforcing value (RRV) of energy-dense snack foods
Time Frame: Weeks 0,12, 24
|
The effect of consuming a healthy DGA style or a Western style diet during weight loss and weight maintenance on the RRV of energy-dense snack food using a computer choice paradigm.
For the computer choice paradigm subjects click the mouse button to play a simulated slot machine games to earn points toward receiving a portion of food or being able to do a non-food related sedentary activity (e.g., watching TV).
|
Weeks 0,12, 24
|
|
Relative reinforcing value (RRV) of exercise
Time Frame: Weeks 0,12, 24
|
The effect of achieving the DGA recommended amounts of exercise during weight loss and weight maintenance on relative reinforcing value of exercise compared to a sedentary activity alternative using a computer choice paradigm.
For the computer choice paradigm subjects click the mouse button to play a simulated slot machine games to earn points toward being able to do a chosen physical activity, such as walking on a treadmill, or a sedentary activity (e.g., watching TV).
|
Weeks 0,12, 24
|
|
Fat and carbohydrate oxidation
Time Frame: Weeks 0,12
|
The effect of diet and exercise on carbohydrate and fat oxidation in response to meals and exercise as measured by whole-room calorimetry
|
Weeks 0,12
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Food Cognitive Interference
Time Frame: Weeks 0, 12, 24
|
The effect of diet and exercise on food cognitive interference, one of the three cognitive domains of executive function, using a computerized Food Stroop test.
|
Weeks 0, 12, 24
|
|
Cognitive flexibility
Time Frame: Weeks 0, 12, 24
|
The effect of diet and exercise on cognitive flexibility, one of the three cognitive domains of executive function, using a computerized Trail-Making test B/A.
|
Weeks 0, 12, 24
|
|
Working memory
Time Frame: Weeks 0, 12, 24
|
The effect of diet and exercise on cognitive flexibility, one of the three cognitive domains of executive function, using the Wisconsin Card Sorting Task.
|
Weeks 0, 12, 24
|
|
Inflammation
Time Frame: Weeks 0, 2, 4, 6, 8, 10, 12, 24
|
The effect of diet and exercise on plasma pro-inflammatory cytokines (e.g., Il-6, MCP-1, TNF-alpha) and anti-inflammatory cytokines (e.g., IL-10, Soluble TNF receptor I and II)
|
Weeks 0, 2, 4, 6, 8, 10, 12, 24
|
|
Change in adipokines
Time Frame: Weeks 0, 2, 4, 6, 8, 10, 12, 24
|
The effect of diet and exercise on plasma adipokines (e.g., adiponectin, resistin)
|
Weeks 0, 2, 4, 6, 8, 10, 12, 24
|
|
Change in myokines
Time Frame: Weeks 0, 2, 4, 6, 8, 10, 12, 24
|
The effect of diet and exercise on plasma myokines (e.g., BDNF, Myostatin, FGF-21, Irisin)
|
Weeks 0, 2, 4, 6, 8, 10, 12, 24
|
|
Change in bile acids
Time Frame: Weeks 0, 2, 4, 6, 8, 10, 12, 24
|
The effect of diet and exercise on plasma bile acids (i.e., glycocholic acid, glyco-CDCA, glyco-HDCA, hyocholic acid, hyodeoxycholic acid)
|
Weeks 0, 2, 4, 6, 8, 10, 12, 24
|
|
Change in blood lipids
Time Frame: Weeks 0, 2, 4, 6, 8, 10, 12, 24
|
The effect of diet and exercise on cholesterol, HDL, triglycerides
|
Weeks 0, 2, 4, 6, 8, 10, 12, 24
|
|
Change in weight control moderators
Time Frame: Weeks 0,12, 24
|
Questionnaires (i.e., three-factor eating questionnaire, reward base eating, food attitudes and behavior survey) that when scored provide a single number will be used to determine the moderating effect of self efficacy, restraint and disinhibition maintaining diet and exercise changes
|
Weeks 0,12, 24
|
|
Change in humoral biomarkers of eating behavior
Time Frame: Weeks 0, 2, 4, 6, 8, 10, 12, 24
|
The effect of diet and exercise on ghrelin, leptin, thyroid hormones, gut peptides, fatty acids
|
Weeks 0, 2, 4, 6, 8, 10, 12, 24
|
|
Gene expression profiles of glucose oxidation
Time Frame: Weeks 0, 2, 4, 6, 8, 10, 12, 24
|
The effect of diet and exercise on gene expression profiles associated with glucose oxidation (i.e., hexokinase, phosphofructokinase, pyruvate dehydrogenase kinase 4, peroxisome proliferator-activated receptor alpha gene expression)
|
Weeks 0, 2, 4, 6, 8, 10, 12, 24
|
|
Gene expression profiles of fat oxidation
Time Frame: Weeks 0, 2, 4, 6, 8, 10, 12, 24
|
The effect of diet and exercise on on gene expression profiles associated with fat oxidation (i.e., fatty acid translocase, fatty acid synthase, acetyl Co-A carboxylase 2, stearoyl Co-A desaturase gene expression)
|
Weeks 0, 2, 4, 6, 8, 10, 12, 24
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Single nucleotide polymorphisms (SNP)
Time Frame: Weeks 0
|
Correlation of SNPs associated with skeletal muscle, catecholamine, executive function and food and exercise reinforcement
|
Weeks 0
|
|
micro RNA (miRNA)
Time Frame: Weeks 0, 12, 24
|
Correlation of miRNAs associated with skeletal muscle, executive function and food and exercise reinforcement
|
Weeks 0, 12, 24
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
October 1, 2024
Primary Completion (Anticipated)
December 1, 2029
Study Completion (Anticipated)
December 1, 2029
Study Registration Dates
First Submitted
June 18, 2020
First Submitted That Met QC Criteria
October 5, 2020
First Posted (Actual)
October 8, 2020
Study Record Updates
Last Update Posted (Estimate)
January 11, 2023
Last Update Submitted That Met QC Criteria
January 9, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- GFHNRC512
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on DGA diet WL & exercise
-
USDA Grand Forks Human Nutrition Research CenterSuspendedClass I Obesity | Overweight , ObesityUnited States
-
Pennington Biomedical Research CenterNational Heart, Lung, and Blood Institute (NHLBI)Recruiting
-
Pennington Biomedical Research CenterThe Cleveland ClinicCompleted
-
USDA, Western Human Nutrition Research CenterRecruitingObesity | Body WeightUnited States
-
University of AberdeenCompleted
-
Wake Forest University Health SciencesNational Institute on Aging (NIA); Wake Forest UniversityCompletedObesity | Sedentary Lifestyle | Weight LossUnited States
-
Universidade Católica PortuguesaAssociação para o Desenvolvimento do Centro Académico de Investigação e Formação...Active, not recruitingCardiovascular Disease RiskPortugal
-
Göteborg UniversityThe Swedish Research Council; Swedish Council for Working Life and Social ResearchCompleted
-
Florida International UniversityTerminatedDiabetes | Frailty | Senior SyndromeUnited States